These highlights do not include all the information needed to use DUAKLIR PRESSAIR safely and effectively. See full prescribing information for DUAKLIR PRESSAIR.DUAKLIR® PRESSAIR® (aclidinium bromide and formoterol fumarate) inhalation powder, for
Healthcare Online Advice - FDA OKs Duaklir Fixed-Dose Combination Inhaler for COPD The US Food and Drug Administration (FDA) has approved a fixed-dose combination of aclidinium bromide 400 μg and formoterol fumarate
Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire
US Food and Drug Administration Approves DUAKLIR® PRESSAIR® (aclidinium/formoterol) for Patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire
AstraZeneca completes transfer of its global rights to Eklira and Duaklir to Covis Pharma
Inhaler technique Genuair
Circassia gets a double shot in the arm from US regulators | AIM:CIR, OTC:CSSPF
Duaklir Genuair Avaialble in Canada - Cost Effecdtive COPD Therapy
How to use a Genuair inhaler | Asthma + Lung UK
Copd inhaler Banque de photographies et d'images à haute résolution - Alamy